Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CEUS for RCC Recurrence Screening
NCT02440334Phase 2Completed
- Sponsor
- Thomas Jefferson University
- Start
- Apr 2015
- Primary completion
- Dec 2017
- Modality
- Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 2 trial of perflutren lipid microspheres in renal cell carcinoma (RCC), sponsored by Thomas Jefferson University. Started Apr 2015; status: completed.
02
Drugs
perflutren lipid microspheres
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT02440334.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02440334.